Cargando…

Comparing Glial Fibrillary Acidic Protein (GFAP) in Serum and Plasma Following Mild Traumatic Brain Injury in Older Adults

Objective: Identification and validation of blood-based biomarkers for the diagnosis and prognosis of mild traumatic brain injury (mTBI) is of critical importance. There have been calls for more research on mTBI in older adults. We compared blood-based protein marker glial fibrillary acidic protein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huebschmann, Nathan A., Luoto, Teemu M., Karr, Justin E., Berghem, Ksenia, Blennow, Kaj, Zetterberg, Henrik, Ashton, Nicholas J., Simrén, Joel, Posti, Jussi P., Gill, Jessica M., Iverson, Grant L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530818/ https://www.ncbi.nlm.nih.gov/pubmed/33071938 http://dx.doi.org/10.3389/fneur.2020.01054

Ejemplares similares

Examining four blood biomarkers for the detection of acute intracranial abnormalities following mild traumatic brain injury in older adults
por: Iverson, Grant L., et al.
Publicado: (2022)

Risk for intracranial hemorrhage in individuals after mild traumatic brain injury who are taking serotonergic antidepressants
por: Isokuortti, Harri, et al.
Publicado: (2022)

A Systematic Review of the Usefulness of Glial Fibrillary Acidic Protein for Predicting Acute Intracranial Lesions following Head Trauma
por: Luoto, Teemu M., et al.
Publicado: (2017)

Differences between blood and cerebrospinal fluid glial fibrillary Acidic protein levels: The effect of sample stability
por: Simrén, Joel, et al.
Publicado: (2022)

Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy Presenting as Mild Encephalopathy with Reversible Splenium Lesion
por: Héraud, Charlotte, et al.
Publicado: (2021)

Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
por: Cicognola, Claudia, et al.
Publicado: (2021)

Blood Levels of Glial Fibrillary Acidic Protein (GFAP) in Patients with Neurological Diseases
por: Mayer, Christoph A., et al.
Publicado: (2013)

Glial Fibrillary Acidic Protein (GFAP): Neuroinflammation Biomarker in Acute Ischemic Stroke
por: Amalia, Lisda
Publicado: (2021)

A case of glial fibrillary acidotic protein (GFAP) meningoencephalitis with rheumatoid arthritis
por: Salari, Mehri, et al.
Publicado: (2023)

Radiographic evolution of myelitis in a case of glial fibrillary acidic protein (GFAP) astrocytopathy
por: Goyne, Christopher E, et al.
Publicado: (2023)

Development of an ultrasensitive microfluidic assay for the analysis of Glial fibrillary acidic protein (GFAP) in blood
por: Fazeli, Badrieh, et al.
Publicado: (2023)

Serum Neurofilament Light, Glial Fibrillary Acidic Protein and Tau Are Possible Serum Biomarkers for Activity of Brain Metastases and Gliomas
por: Hepner, Adriana, et al.
Publicado: (2019)

Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer's disease and vascular pathology
por: Shir, Dror, et al.
Publicado: (2022)

Tau as a fluid biomarker of concussion and neurodegeneration
por: Hossain, Iftakher, et al.
Publicado: (2022)

Regulatory mechanisms for 3′-end alternative splicing and polyadenylation of the Glial Fibrillary Acidic Protein, GFAP, transcript
por: Blechingberg, Jenny, et al.
Publicado: (2007)

Blood neurofilament light in remote settings: Alternative protocols to support sample collection in challenging pre‐analytical conditions
por: Simrén, Joel, et al.
Publicado: (2021)

Supratentorial hydrocephalus with an anti‐glial fibrillary acidic protein (GFAP) antibody‐positive status: A case report
por: Tang, Lei, et al.
Publicado: (2022)

Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer’s disease with multi-modal PET and plasma GFAP
por: Chiotis, Konstantinos, et al.
Publicado: (2023)

Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease
por: Chatterjee, Pratishtha, et al.
Publicado: (2021)

Plasma autoantibodies to glial fibrillary acidic protein (GFAP) react with brain areas according to Braak staging of Parkinson’s disease
por: Gschmack, Eva, et al.
Publicado: (2022)

Ultrasensitive Determination of Glial-Fibrillary-Acidic-Protein (GFAP) in Human Serum-Matrix with a Label-Free Impedimetric Immunosensor
por: Ozcelikay, Goksu, et al.
Publicado: (2022)

Effects of pre‐analytical procedures on blood biomarkers for Alzheimer's pathophysiology, glial activation, and neurodegeneration
por: Ashton, Nicholas J., et al.
Publicado: (2021)

Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease
por: Pereira, Joana B, et al.
Publicado: (2021)

Development of a novel, sensitive translational immunoassay to detect plasma glial fibrillary acidic protein (GFAP) after murine traumatic brain injury
por: Button, Emily B., et al.
Publicado: (2021)

Magnetic Resonance Imaging Characteristics of Autoimmune Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy: A Pediatric Series in Southwest China
por: Cheng, Weiqin, et al.
Publicado: (2023)

Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
por: Benedet, Andréa L., et al.
Publicado: (2021)

Peripheral nervous system involvement accompanies central nervous system involvement in anti-glial fibrillary acidic protein (GFAP) antibody-related disease
por: Theuriet, Julian, et al.
Publicado: (2023)

Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation
por: Jiang, Xiaotong, et al.
Publicado: (2023)

Plasma GFAP in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort study
por: O'Connor, Antoinette, et al.
Publicado: (2023)

GFAP and S100B: What You Always Wanted to Know and Never Dared to Ask
por: Janigro, Damir, et al.
Publicado: (2022)

Plasma glial fibrillary acidic protein and neurofilament light chain, but not tau, are biomarkers of sports-related mild traumatic brain injury
por: Laverse, Etienne, et al.
Publicado: (2020)

Cross‐sectional and longitudinal evaluation of plasma glial fibrillary acidic protein to detect and predict clinical syndromes of Alzheimer's disease
por: Ally, Madeline, et al.
Publicado: (2023)

Glial Fibrillary Acidic Protein (GFAP) as a Mesenchymal marker of Early Hepatic Stellate Cells Activation in Liver Fibrosis in Chronic Hepatitis C Infection
por: Hassan, Sobia, et al.
Publicado: (2014)

Prolonged Febrile Seizures Impair Synaptic Plasticity and Alter Developmental Pattern of Glial Fibrillary Acidic Protein (GFAP)-Immunoreactive Astrocytes in the Hippocampus of Young Rats
por: Griflyuk, Alexandra V., et al.
Publicado: (2022)

Autoimmune Glial Fibrillary Acidic Protein (Gfap) Astrocytopa-Thy Accompanied with Reversible Splenial Lesion Syndrome (RESLES): A Case Report and Literature Review
por: Wang, Siting, et al.
Publicado: (2023)

Mode Characterization and Sensitivity Evaluation of a Surface Acoustic Wave (SAW) Resonator Biosensor: Application to the Glial-Fibrillary-Acidic-Protein (GFAP) Biomarker Detection
por: Passeri, Antonio Matteo, et al.
Publicado: (2023)

GFAp and tau protein as predictors of neurological outcome after out-of-hospital cardiac arrest: A post hoc analysis of the COMACARE trial
por: Humaloja, Jaana, et al.
Publicado: (2022)

Modelling and Characterization of Glial Fibrillary Acidic Protein
por: Deka, Hemchandra, et al.
Publicado: (2015)

Autoimmune glial fibrillary acidic protein astrocytopathy
por: Kunchok, Amy, et al.
Publicado: (2019)

Clinical utility of serum glial fibrillary acidic protein in glial neoplasm
por: Yadav, Nidhi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ue546pacv4ijfi1hmblnhokh96